SMO ClinPlus CO.,LTD. (SHE:301257)
China
· Delayed Price · Currency is CNY 64.02
+0.28 (0.44%)
Mar 6, 2026, 4:00 PM EST
SMO ClinPlus CO.,LTD. Revenue
SMO ClinPlus CO.,LTD. had revenue of 218.91M CNY in the quarter ending September 30, 2025, with 9.84% growth. This brings the company's revenue in the last twelve months to 819.09M, up 1.14% year-over-year. In the year 2024, SMO ClinPlus CO.,LTD. had annual revenue of 803.73M with 5.75% growth.
Revenue (ttm)
819.09M
Revenue Growth
+1.14%
P/S Ratio
5.99
Revenue / Employee
191.78K
Employees
4,271
Market Cap
4.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 803.73M | 43.69M | 5.75% |
| Dec 31, 2023 | 760.04M | 173.81M | 29.65% |
| Jan 1, 2023 | 586.23M | 83.27M | 16.55% |
| Dec 31, 2021 | 502.97M | 167.68M | 50.01% |
| Dec 31, 2020 | 335.29M | 31.75M | 10.46% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thalys Medical Technology Group | 1.25B |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Berry Genomics Co.,Ltd | 941.16M |
| Guangdong Hybribio Biotech | 691.16M |
| Medicalsystem Biotechnology | 1.47B |
| Cowealth Medical China | 777.03M |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |